Table 3 Gender-based differences in anabolic and androgenic steroid use
Variable | Total n (%) | Men n (%) | Women n (%) | Statistics |
|---|---|---|---|---|
Anabolic-Androgenic Steroid | Ā | Ā | Ā | Ā |
āYes | 1718(47.68%) | 984(53.05%) | 734(41.99%) | 0.001* |
āNo | 1885(52.32%) | 871(46.95%) | 1014(58.01%) | 0.001* |
Consumption Method | Ā | Ā | Ā | Ā |
āInjection | 688(40.05%) | 495(50.30%) | 193(26.29%) | 0.001* |
āOral Intake | 714(41.56%) | 354(35.97%) | 360(49.05%) | 0.001* |
āGel and Cream | 183(10.65) | 88(8.95%) | 95(12.94%) | 0.048* |
āAll | 133(7.74%) | 47(4.78%) | 86(11.72%) | 0.031* |
Type | Ā | Ā | Ā | Ā |
āTestosterone | 396(23.05%) | 290(29.47%) | 106(14.44%) | 0.001* |
āDianabol | 382(22.23%) | 231(23.48%) | 151(20.57%) | 0.156 |
āAnadrol | 325(18.92%) | 146(14.84%) | 179(24.39%) | 0.011* |
āTrenbolone | 66(3.84%) | 43(4.37%) | 23(3.13%) | 0.253 |
āTurinabol | 148(8.62%) | 102(10.36%) | 46(6.27%) | 0.029* |
āWinstrol | 401(23.34%) | 172(17.48%) | 229(31.20%) | 0.001* |